Trial Profile
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms Project PrEPare
- 08 Jun 2019 Results of pooled analysis of extension phase assessing Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men form this and NCT01769456 published in the Clinical Infectious Diseases
- 24 Aug 2017 Results of this trial and another one (refer CTP: 700228246) assessing measures of adherence were published in the Clinical Infectious Diseases
- 13 Sep 2016 Results published in the JAIDS.